We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CpG 1018

News List

Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate prnewswire
March 25, 2021
Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics such as vaccines and therapeutics for the world's most debilitating diseases, and Dynavax Technologies Corporation, a biopharmaceutical ...
First Participant Dosed in COVID-19 Vaccine Trial in Taiwan, China Region americanpharmaceuticalreview
January 29, 2021
Medigen Vaccine Biologics (MVC) and Dynavax Technologies announced the first participant has been dosed in the Phase 2 clinical trial evaluating MVC's COVID-19 vaccine candidate, MVC-COV1901.
Indian firm Biological E initiates clinical trial of Covid-19 vaccine candidate pharmaceutical-technology
November 17, 2020
Indian pharma firm Biological E (BE) has initiated a Phase I/II clinical trial to evaluate the safety and immunogenicity of its Covid-19 subunit vaccine candidate.
Valneva, Dynavax Enter COVID-19 Vax Supply Pact contractpharma
September 16, 2020
Dynavax will supply CpG 1018 to produce up to 100 million doses of VLA2001 vaccine in 2021.